<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">persmed</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал персонализированной медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal for Personalized Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2782-3806</issn><issn pub-type="epub">2782-3814</issn><publisher><publisher-name>ФОНД АЛМАЗОВА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18705/2782-3806-2024-4-5-421-430</article-id><article-id custom-type="edn" pub-id-type="custom">WPCGMG</article-id><article-id custom-type="elpub" pub-id-type="custom">persmed-288</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОНКОЛОГИЯ, ЛУЧЕВАЯ ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ONCOLOGY, RADIATION THERAPY</subject></subj-group></article-categories><title-group><article-title>Трансрадиальный и трансфеморальный доступы при химиоэмболизации печеночных артерий у пациентов со злокачественными новообразованиями печени</article-title><trans-title-group xml:lang="en"><trans-title>Transradial and transfemoral access in hepatic artery chemoembolization in patients with hepatic malignancies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Логинов</surname><given-names>М. О.</given-names></name><name name-style="western" xml:lang="en"><surname>Loginov</surname><given-names>M. O.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Логинов Максим Олегович - заведующий отделением рентгенохирургических методов диагностики и лечения ГБУЗ РКБ им. Г. Г. Куватова.</p><p>Уфа</p></bio><bio xml:lang="en"><p>Loginov Maxim O. - head of department X-ray surgical methods of diagnosis and treatment of the Republic Clinical Hospital named G. G. Kuvatova.</p><p>Ufa</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Файзуллин</surname><given-names>Э. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Fayzullin</surname><given-names>E. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Файзуллин Эдуард Салаватович - врач по рентгенэндоваскулярным диагностике и лечению отделения рентгенохирургических методов диагностики и лечения ГБУЗ РКБ им. Г. Г. Куватова.</p><p>Ул. Достоевского, 132, Уфа, Республика Башкортостан, 450005</p></bio><bio xml:lang="en"><p>Fayzullin Eduard S. - surgeon of department X-ray surgical methods of diagnosis and treatment of the Republic Clinical Hospital named G. G. Kuvatova.</p><p>Dostoevsky str., 132, Ufa, Republic of Bashkortostan, 450005</p></bio><email xlink:type="simple">ed-fayzullin@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шакуров</surname><given-names>Д. Ф.</given-names></name><name name-style="western" xml:lang="en"><surname>Shakurov</surname><given-names>D. F.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шакуров Данил Фаилевич - врач по рентгенэндоваскулярным диагностике и лечению отделения рентгенохирургических методов диагностики и лечения ГБУЗ РКБ им. Г. Г. Куватова.</p><p>Уфа</p></bio><bio xml:lang="en"><p>Shakurov Danil F. - surgeon of department X-ray surgical methods of diagnosis and treatment of the Republic Clinical Hospital named G. G. Kuvatova.</p><p>Ufa</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения «Республиканская клиническая больница имени Г.Г. Куватова»; Федеральное государственное бюджетное образовательное учреждение высшего образования «Башкирский государственный медицинский университет» Министерства здравоохранения Российской Федерации</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republic Clinical Hospital named G.G. Kuvatova; Bashkir State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Государственное бюджетное учреждение здравоохранения «Республиканская клиническая больница имени Г.Г. Куватова»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Republic Clinical Hospital named G.G. Kuvatova</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>18</day><month>11</month><year>2024</year></pub-date><volume>4</volume><issue>5</issue><fpage>421</fpage><lpage>430</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Логинов М.О., Файзуллин Э.С., Шакуров Д.Ф., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Логинов М.О., Файзуллин Э.С., Шакуров Д.Ф.</copyright-holder><copyright-holder xml:lang="en">Loginov M.O., Fayzullin E.S., Shakurov D.F.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://persmed.elpub.ru/jour/article/view/288">https://persmed.elpub.ru/jour/article/view/288</self-uri><abstract><sec><title>Цель</title><p>Цель. Оценить потенциал и перспективы трансрадиального доступа в качестве альтернативы трансфеморальному доступу при проведении процедуры химиоэмболизации печеночной артерии (ХЭПА) в лечении пациентов со злокачественными новообразованиями печени.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Пациенты, которым проводилась ХЭПА, были разделены на две группы в зависимости от артериального доступа: через лучевую артерию (первая группа) или через бедренную артерию (вторая группа). Далее был проведен ретроспективный анализ клинических показателей и эффективности этого метода лечения, технических аспектов и частоты осложнений при сравнении данных групп пациентов, которым была проведена ХЭПА.</p></sec><sec><title>Результаты</title><p>Результаты. Исследование показало, что радиальный доступ обеспечивает более высокие технические результаты и клиническую эффективность. Пациенты с лучевым доступом имели существенно меньшую частоту спазмов печеночной артерии, проводили меньше времени в стационаре в послеоперационном периоде. Однако показатели боли, оцененные с использованием визуальной аналоговой шкалы (VAS), статистически оставались схожими в обеих группах. Применение радиального доступа для ХЭПА также привело к существенному снижению общей частоты осложнений (72,5 % по сравнению с 84,1 % при трансфеморальном доступе, P = 0,027).</p></sec><sec><title>Заключение</title><p>Заключение. Наши результаты подтверждают, что лучевой доступ представляет собой эффективную, более безопасную и перспективную альтернативу бедренному доступу при проведении ХЭПА у пациентов со злокачественными новообразованиями печени.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Objective</title><p>Objective. To evaluate the potential and prospects of the transradial approach as an alternative to the transfemoral approach during hepatic artery chemoembolization (HAE) in the treatment of patients with liver malignancies.</p></sec><sec><title>Material and methods</title><p>Material and methods. Patients, who underwent CEPA, were divided into two groups depending on the arterial access: through the radial artery (first group) or through the femoral artery (second group). Next, a retrospective analysis of the clinical indicators and effectiveness of this treatment method, technical aspects and complication rates, was carried out when comparing the use of given groups in patients who underwent CEPA.</p></sec><sec><title>Results</title><p>Results. The study showed that the radial approach provided superior technical results and clinical effectiveness. Patients with radial access had a significantly lower incidence of hepatic artery spasms and spent less time in the hospital in the postoperative period. However, pain scores assessed using the visual analogue scale (VAS) remained statistically similar in both groups. The use of the radial approach for CEPA also resulted in a significant reduction in the overall complication rate (72.5 % versus 84.1 % with the transfemoral approach, P = 0.027).</p></sec><sec><title>Conclusion</title><p>Conclusion. Our results confirm that the radial approach is an effective, safer, and promising alternative to the femoral approach for CEPA in patients with liver malignancies.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>бедренный доступ</kwd><kwd>злокачественные новообразования печени</kwd><kwd>лучевой доступ</kwd><kwd>химиоэмболизация</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chemoembolization</kwd><kwd>femoral access</kwd><kwd>malignant liver tumors</kwd><kwd>radial access</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению России в 2022 году. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России. 2022: (илл.)239. ISBN 978-5-85502-283-4].</mixed-citation><mixed-citation xml:lang="en">Kaprin AD, Starinskij VV, Shahzadova AO. The state of oncological care for the Russian population in 2022. Moscow: P. Hertsen MORI — branch of the FSBI NMRRC of the Ministry of Health of Russia. 2022: (ill)239. ISBN 978-5-85502-283–4. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–14.</mixed-citation><mixed-citation xml:lang="en">Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391(10127):1301–14.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Huynh H, Ng WH, Soo KC. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma. Int J Mol Sci. 2023 Dec 19;25(1):17.</mixed-citation><mixed-citation xml:lang="en">Huynh H, Ng WH, Soo KC. Everolimus Acts in Synergy with Vinorelbine to Suppress the Growth of Hepatocellular Carcinoma. Int J Mol Sci. 2023 Dec 19;25(1):17.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Tao C, Wu F, Liu Y, et al. Long-term outcome of centrally located hepatocellular carcinoma treated by neoadjuvant radiotherapy and radical resection: a propensity score matched study. Ann Med Surg (Lond). 2023 Nov 16;86(1):78–84.</mixed-citation><mixed-citation xml:lang="en">Tao C, Wu F, Liu Y, et al. Long-term outcome of centrally located hepatocellular carcinoma treated by neoadjuvant radiotherapy and radical resection: a propensity score matched study. Ann Med Surg (Lond). 2023 Nov 16;86(1):78–84.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Hao X, Fan R, Zeng HM, et al. Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection. J Clin Transl Hepatol. 2023 Dec 28;11(7):1508–1519.</mixed-citation><mixed-citation xml:lang="en">Hao X, Fan R, Zeng HM, et al. Hepatocellular Carcinoma Risk Scores from Modeling to Real Clinical Practice in Areas Highly Endemic for Hepatitis B Infection. J Clin Transl Hepatol. 2023 Dec 28;11(7):1508–1519.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Tayal R, DiVita M, Sossou CW, et al. Efficacy of Manual Hemostasis for Percutaneous Axillary Artery Intra-Aortic Balloon Pump Removal. J Interv Cardiol. 2020 Jul 26;2020:8375878.</mixed-citation><mixed-citation xml:lang="en">Tayal R, DiVita M, Sossou CW, et al. Efficacy of Manual Hemostasis for Percutaneous Axillary Artery Intra-Aortic Balloon Pump Removal. J Interv Cardiol. 2020 Jul 26;2020:8375878.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Varela-Cancelo A, Salgado-Fernandez J, Calvino-Santos R, et al. Successful transfemoral management of transcatheter aortic valve embolization into left ventricle. Eur Heart J. 2020;41(41):4074.</mixed-citation><mixed-citation xml:lang="en">Varela-Cancelo A, Salgado-Fernandez J, Calvino-Santos R, et al. Successful transfemoral management of transcatheter aortic valve embolization into left ventricle. Eur Heart J. 2020;41(41):4074.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sainamthip P, Kongphanich C, Prasongsook N, et al. Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study. World J Clin Cases. 2021 Oct 26;9(30):9059–9069.</mixed-citation><mixed-citation xml:lang="en">Sainamthip P, Kongphanich C, Prasongsook N, et al. Single dose dexamethasone prophylaxis of postembolisation syndrome after chemoembolisation in hepatocellular carcinoma patient: A randomised, double-blind, placebo-controlled study. World J Clin Cases. 2021 Oct 26;9(30):9059–9069.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tsigkas G, Papanikolaou A, Apostolos A, et al. Preventing and Managing Radial Artery Occlusion following Transradial Procedures: Strategies and Considerations. J Cardiovasc Dev Dis. 2023 Jun 30;10(7):283.</mixed-citation><mixed-citation xml:lang="en">Tsigkas G, Papanikolaou A, Apostolos A, et al. Preventing and Managing Radial Artery Occlusion following Transradial Procedures: Strategies and Considerations. J Cardiovasc Dev Dis. 2023 Jun 30;10(7):283.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ghosh A, Zhang J, Akhter NM. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma. J Clin Imaging Sci. 2022 May 12;12:27.</mixed-citation><mixed-citation xml:lang="en">Ghosh A, Zhang J, Akhter NM. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma. J Clin Imaging Sci. 2022 May 12;12:27.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44(2):349–56.</mixed-citation><mixed-citation xml:lang="en">Agostoni P, Biondi-Zoccai GG, de Benedictis ML, et al. Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; systematic overview and meta-analysis of randomized trials. J Am Coll Cardiol. 2004;44(2):349–56.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access. Diagn Interv Radiol. 2016 Sep-Oct;22(5):444–9. DOI: 10.5152/dir.2016.15571.</mixed-citation><mixed-citation xml:lang="en">Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access. Diagn Interv Radiol. 2016 Sep-Oct;22(5):444–9. DOI: 10.5152/dir.2016.15571.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sciahbasi A, Fischetti D, Picciolo A, et al. Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures. Int J Cardiol. 2009;137(3):199–205.</mixed-citation><mixed-citation xml:lang="en">Sciahbasi A, Fischetti D, Picciolo A, et al. Transradial access compared with femoral puncture closure devices in percutaneous coronary procedures. Int J Cardiol. 2009;137(3):199–205.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Minici R, Serra R, Giurdanella M, et al. Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver. J Pers Med. 2023 Apr 7;13(4):640.</mixed-citation><mixed-citation xml:lang="en">Minici R, Serra R, Giurdanella M, et al. Efficacy and Safety of Distal Radial Access for Transcatheter Arterial Chemoembolization (TACE) of the Liver. J Pers Med. 2023 Apr 7;13(4):640.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">You K, Guo T, Sun D, et al. Transradial versus transfemoral approach for TACE: a retrospective study. BMC Gastroenterol. 2023 Jan 11;23(1):11. DOI: 10.1186/s12876-023-02646-1.</mixed-citation><mixed-citation xml:lang="en">You K, Guo T, Sun D, et al. Transradial versus transfemoral approach for TACE: a retrospective study. BMC Gastroenterol. 2023 Jan 11;23(1):11. DOI: 10.1186/s12876-023-02646-1.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Meertens MM, Ng E, Loh SEK, et al. Choong AMTL. Transradial Approach for Aortoiliac and Femoropopliteal Interventions: A Systematic Review and Meta-analysis. J Endovasc Ther. 2018 Oct;25(5):599–607.</mixed-citation><mixed-citation xml:lang="en">Meertens MM, Ng E, Loh SEK, et al. Choong AMTL. Transradial Approach for Aortoiliac and Femoropopliteal Interventions: A Systematic Review and Meta-analysis. J Endovasc Ther. 2018 Oct;25(5):599–607.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Du N, Yang MJ, Ma JQ, et al. Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access. Transl Cancer Res. 2019 Sep;8(5):1795–1805.</mixed-citation><mixed-citation xml:lang="en">Du N, Yang MJ, Ma JQ, et al. Transradial access chemoembolization for hepatocellular carcinoma in comparation with transfemoral access. Transl Cancer Res. 2019 Sep;8(5):1795–1805.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access. Diagn Interv Radiol. 2016;22(5):444–9.</mixed-citation><mixed-citation xml:lang="en">Kis B, Mills M, Hoffe SE. Hepatic radioembolization from transradial access: initial experience and comparison to transfemoral access. Diagn Interv Radiol. 2016;22(5):444–9.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Ghosh A, Zhang J, Akhter NM. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma. J Clin Imaging Sci. 2022 May 12;12:27.</mixed-citation><mixed-citation xml:lang="en">Ghosh A, Zhang J, Akhter NM. Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma. J Clin Imaging Sci. 2022 May 12;12:27.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Iezzi R, Pompili M, Posa A, et al. Transradial versus transfemoral access for hepatic chemoembolization: intrapatient prospective single-center study. J Vasc Interv Radiol. 2017;28(9):1234–9.</mixed-citation><mixed-citation xml:lang="en">Iezzi R, Pompili M, Posa A, et al. Transradial versus transfemoral access for hepatic chemoembolization: intrapatient prospective single-center study. J Vasc Interv Radiol. 2017;28(9):1234–9.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Satti SR, Vance AZ. Radial Access for Neurovascular Procedures. Semin Intervent Radiol. 2020 Jun;37(2):182-191. doi: 10.1055/s-0040-1709173. Epub 2020 May 14.</mixed-citation><mixed-citation xml:lang="en">Satti SR, Vance AZ. Radial Access for Neurovascular Procedures. Semin Intervent Radiol. 2020 Jun;37(2):182-191. doi: 10.1055/s-0040-1709173. Epub 2020 May 14.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Mercuri M, Mehta S, Xie C, et al. Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. JACC Cardiovasc Interv. 2011;4(3):347–52.</mixed-citation><mixed-citation xml:lang="en">Mercuri M, Mehta S, Xie C, et al. Radial artery access as a predictor of increased radiation exposure during a diagnostic cardiac catheterization procedure. JACC Cardiovasc Interv. 2011;4(3):347–52.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
